Imaging as a biomarker in drug discovery for Alzheimer's disease: is MRI a suitable technology?
Imaging as a biomarker in drug discovery for Alzheimer's disease: is MRI a suitable technology?
复制标题
DOI:
10.1186/alzrt276
复制
发表时间:
2014
期刊:
影响因子:
--
通讯作者:
Potter WZ
中科院分区:
文献类型:
--
作者:
Merlo Pich E;Jeromin A;Frisoni GB;Hill D;Lockhart A;Schmidt ME;Turner MR;Mondello S;Potter WZ
This review provides perspectives on the utility of magnetic resonance imaging (MRI) as a neuroimaging approach in the development of novel treatments for Alzheimer’s disease. These considerations were generated in a roundtable at a recent Wellcome Trust meeting that included experts from academia and industry. It was agreed that MRI, either structural or functional, could be used as a diagnostic, for assessing worsening of disease status, for monitoring vascular pathology, and for stratifying clinical trial populations. It was agreed also that MRI implementation is in its infancy, requiring more evidence of association with the disease states, test-retest data, better standardization across multiple clinical sites, and application in multimodal approaches which include other imaging technologies, such as positron emission tomography, electroencephalography, and magnetoencephalography.
登录
查看更多内容
影响因子:
3.7
作者:
Dyrba M;Ewers M;Wegrzyn M;Kilimann I;Plant C;Oswald A;Meindl T;Pievani M;Bokde AL;Fellgiebel A;Filippi M;Hampel H;Klöppel S;Hauenstein K;Kirste T;Teipel SJ;EDSD study group
通讯作者:
EDSD study group
DOI:
10.3233/jad-2012-112165
发表时间:
2012
期刊:
Journal of Alzheimer's disease : JAD
影响因子:
--
作者:
Gold BT;Jiang Y;Powell DK;Smith CD
通讯作者:
Smith CD
影响因子:
9.9
作者:
Chhatwal, Jasmeer P.;Schultz, Aaron P.;Sperling, Reisa A.
通讯作者:
Sperling, Reisa A.
影响因子:
38.1
作者:
Frisoni, Giovanni B.;Fox, Nick C.;Jack, Clifford R., Jr.;Scheltens, Philip;Thompson, Paul M.
通讯作者:
Thompson, Paul M.
影响因子:
4.2
作者:
Johnson, S. C.;Schmitz, T. W.;Alexander, G. E.
通讯作者:
Alexander, G. E.